CONTINUED BLEEDING OF COVID VACCINE STOCKS

Continued bleeding for COVID VACCINE STOCKS. Values of these stocks drip, drip, dripping away. Another 1.2% loss on average. 17 stocks decline with nine managing a gain with one unchanged. 

The biggest loser today was Arcuturus down almost 8%. Tonix also fell almost 8%. CureVac and Heat Biologics lost 7% and 6% respectively.  Several others had sizable losses.

Generex Biotechnology had the best performance today - bouncing back with a 16% gain. This stock is still the poorest performer of the group and has suffered significant losses in the past few weeks.  VBI Vaccines continued its recent move higher with an almost 7% gain.

 

TOP AND BOTTOM PERFORMING TOP TEN - MARCH 1 TO AUGUST 29

 

Miserable week ends on a flat note. Heat Biologics is top COVID VACCINE STOCK today.

Heat Biologics leads the way with an 8% gain and Nano Viricides gains almost 7%.  On the downside, Arcuturus lost almost 5% and Dynavax lost almost 4.5%.

Overall, the average loss for the stocks was 0.4% to end an awful week for these stocks on a flat note. There were 15 stocks to the downside and 11 to the upside with one unchanged. 

We have taken Biondvax out of our index as it does not have a COVID VACCINE candidate so we are back down to 27 stocks.

 

COVID VACCINE STOCKS CRUMBLING - VBI VACCINES only bright spot.

VBI Vaccines explodes up by one third. That is the end of the good news. 

Fully 22 stocks were down, with five up and one flat. These stocks tumbled on an average of 2.7%. Without VBI the average loss would have been close to 4%. These stocks are essentially crumbling as the month of August crawls to the end.

Two smaller stocks were particularly hard hit:  PDS and Generex - both falling over 13%. The erstwhile top Covid Vaccine Stock, Novavax, got pummeled, falling over 6%. Inovio, GeoVax, Heat Biologics and Vaxart had high single digit per centage losses.

COVID VACCINE STOCKS SAG AGAIN - Altimmune plunges, Moderna strong

COVID VACCINE STOCKS give back yesterday's gains. Eighteen stocks fall with 10 on making gains. The average stock lost 1.3%. 

Moderna had its best day in many with a gain of over 6% based on the release of further positive data on its vaccine candidate. Tonix was up almost 12%. Altimmune continues to hemorrhage value, dropping almost 15%.

 

COVID VACCINE STOCKS stabilize with 1% gain

A mini-bounce back day for COVID VACCINE STOCKS. The average stock gained 1% after losing an average of 6% yesterday. 16 stocks were up and 12 down. The biggest loser was Vaxart, down 5.5%. Novavax and Biondvax also lost over 5%. 

The winner today was HeatBiologics with a gain of almost 11%. Generex also had a good day, up over 6%. Atara Bio also gained over 5%.

 

COVID VACCINE STOCK ARMAGEDDON

Devastating day for COVID VACCINE STOCKS. A record, 24 of 28 stocks fall, many precipitously. 

The average stock fell over 6% for the worst results since the pandemic began. 

iBio was a rare bright spot, gained back a large chunk of the calamitous crash it endured last week.

The roster of devastation is extensive:  Sorrento down over 19%, Vir also hammered by almost 19%, Nano Viricides mauled: down 18.5%. Many other losers, too numerous to mention. 

We are in a bear market for these stocks.

 

iBio takes biggest hit in Bottom Ten performers chart

New stock CureVac takes 8th spot from the bottom after six days of trading. This boosts NanTKwest out of the bottom ten. iBio takes the biggest hit. From returning 6% last week, it fell to loosing 31% this week and is the third worst performing COVID VACCINE STOCK. 

Adaptive Biotechnologies had the biggest gain. From a return of 40%, it moved to a return of 54%, moving from 8th worst performer to 9th. 

 

No changes in TOP TEN

 

Novavax still the #1 COVID VACCINE STOCK but pulls back this week. Only three of the top ten managed positive returns this week: BiondVax, Arcturus and VBI.

Covid Vaccine bloodbath continues - with a few exceptions

Miserable end to a miserable week as red ink keeps flowing. The average loss for these stocks was 2.2% today. For the third day out of four, 20 stocks fell with 8 gaining value. Only Arcturus Therapeutics has managed to gain on all three of these days and on each day this week.

BioNTech had a strong day - up over 10% based on positive pre-clinical data from its work with Pfizer on a vaccine. Biondvax was the next top performing stock - up over 9%. Arcturus was up by 6.5% and little OncoSec managed to gain almost 5%.

Besides these notable winners, it was a very down day for these stocks. iBio continued its descent with another 13% drop. GeoVax lost almost 11%. There were several other companies with high single digit losses: Sorrento, Altimmune, NantKwest, VBI, Vaxart, Generex, Tonix and Inovio.

After an amazing return of 4.5% on average on Monday, thanks to the CureVac IPO, the week went straight south losing 6.5% in total. 

FLAT RESULTS FOR COVID VACCINE STOCKS

After two losing days, 14 COVID VACCINE STOCKS were up and 14 down today to register a flat day overall.  The average return for the stocks was a loss of just under 0.3%. 

CureVac continued to bounce with a large 16% gain today based on news of vaccine arrangements with the EU.  Altimmune had a good day of just under 7%.

iBio lead on the downside with a 17% drop. Heat Biologics, GeoVax, Nano Viricides and Tonix also had poor day with high single digit losses. The smaller companies continued to tend lower compared to the large market value stocks.

 

Bleeding continues for COVID VACCINE STOCKS

For the second straight day 20 of the 28 COVID VACCINE STOCKS fell. On average these stocks lost 2.5%. CureVac suffered its second straight double digit fall after going straight up with its launch last Friday.  Sorrento tumbled 10% after the dismissal of the CFO yesterday. VBI, IBIO and Generex all witnessed high single digit losses. The most consistent losses were in the small market value stocks. All eight winners today were in the top half of the 28 in terms of market value.

The winning COVID VACCINE STOCK today was Atara Biotherapeutics, up 7 1/2%.

There are only three stocks that managed to post gains in both of the last two days: Emergenty BioSolutions, Adaptive Biotechnologies and Arcturus Therapeutics.

 

CureVac falls back to earth - Generex Bio leads to the upside

Down day for COVID VACCINE STOCKS. The stocks were down today an average of 1.5%. Fully 20 stocks fell with only eight up. Moderna's market value has dropped to $26.5 Billion after losing almost 4% today. It was well over $30 Billion just a few weeks ago.

The darling since its debut last Friday, CureVac, fell back to earth with a 15% drop to lead on the downside. Dynavax, Vaxart, Novavax and Heat Biologics had notably bad days falling in the 5% to 6% range.

The poorest performer of the COVID VACCINE STOCKS to date, Generex Bio, registered its largest gain yet and the for the first time was the top performing stock, racing ahead 14.5%.

 

CureVac joins COVID VACCINE STOCKS with a blowout day - up 38%

 

The German vaccine maker CureVac joined the COVID VACCINE group (now 28 companies) with a follow up blow out day from its first trading day last Friday. Today the company rose another 38%. 

Overall, it was the good times rolling again for these stocks after some choppy  trading the past several sessions. The average stock was up 4.5%. Fully 23 were in the green with only 5 losing value.

While CureVac stole the spotlight, there were several other notable performances. Both Arcturus Therapeutics and Vaxart had double digit gains while Dynavax, VBI and Novavax also had high single digit gains.

None of the stocks were down much. Sorrento lost the most - almost 3%.

 

Nantkwest replaces TBIO in the bottom 10 COVID VACCINE STOCKS

Bottom 10 COVID VACCINE STOCKS remain stable after tough week. 

NanTKwest fell into 10th from bottom. It had returned 97% last week, but fell to a return of only 83% this week. Translate Bio was a 94% returner and dropped to 92% and is now out of the bottom ten.

Emergent was the top relative gainer of all COVID VACCINE STOCKS. It now has returned 141% as compared to 136% last week. 

Only three other stocks managed to increase the percentage return this week (ADPT, VIR and GNBT).

The overall return falls to 174% - Vaxart re-enters top ten.

All of the TOP TEN COVID VACCINE STOCKS fell this week. But the order did not change much. The top five remain in order:  Novavax, Altimmune, Sorrento, Heat Biologics and Biondvax.

Vaxart's return was down a mere 2% from 220% to 218% so it regained its place in the top ten -- now 8th overall. PDS Biotech fell out of the top ten.

Overall, these stocks have now returned 174% since March 1 after several weeks of returning over 200%. 

The entry of CureVac into the group next week will be interesting since it gained over 200% on its first day of trading on Friday.  

 

Relatively Flat Day - Novavax bounces back

Novavax bounced back strong with an almost 10% gain. Little GeoVax also gained back some recent losses with an almost 9% gain.

Other than that it was a moderately down day with the average COVID VACCINE STOCKS down 1.5%.  There were more downward than upward stocks by a ratio of two to one. 

In particular, several smaller stocks got hammered today: Tonix, Heat Biologics, OncoSec all had significant falls.

Curevac, another mRNA biotech in the Covid Vaccine hunt, debuted today, up by more than 200% from the initial offering price.

Bounce Back day for COVID VACCINE STOCKS - TONIX Pharma up 28%

COVID VACCINE STOCKS bounced back today after two serious down days, gaining 4%. Tonix Pharma lead the way with a 28% gain as it was issued a biopharma patent today.  Fully 20 of these stocks were up with six down and one flat.

Heat Biologics also shot up over 17% based on positive pre-clinical data on its COVID VACCINE candidate.

iBio was the top COVID VACCINE STOCK in the BARRON'S 100, climbing 8 1/2%. VBI Vaccines also had a strong day up over 7%. Little GeoVax gained almost 9% after several days of losses.

The biggest drop came from Moderna, down 2 1/2%, its market value dropping below $27 Billion.

Big losses for COVID VACCINE STOCKS again - Novavax falls over 16%

Another tough day for COVID VACCINE STOCKS. Fully 21 fell -- eight by more than 10% -- with only six scoring a positive day.  All six with gains were in the top seven of market cap. Only Novavax which has the fourth highest market value fell today, as its steep slide continued for a second day.  It was the poorest performer.

The average stock fell 5% after a 9% collapse yesterday. 

Apart from Novavax, Heat Biologics fell over 15%, Vaxart which returned its gains from yesterday, fell 14%. GeoVax, Tonix, iBio and IMV also had double digit losses.

 

COVID VACCINE STOCKS CORRECT. Vaxart only winner

Putin announced that Russia had a successful vaccine - one that his daughter took and only got a mild fever. That's all that was needed for COVID VACCINE STOCKS to get crushed today. 

The average loss was a scary 9%. All but Vaxart fell - thanks to announcing progress on its nasal vaccine. 

Sorrento gave back most of its amazing gain yesterday, falling by a quarter. Other suffering major bloodletting was: iBio, Inovio and PDS Bio (down over 20%). Even high-flying Novavax had its worst day -- down over 16%. 

It's hard to believe the news from Russia really meant that much since this was a predictable PR coup for Putin -- their candidate has taken, to be charitable, an abbreviated approach to testing.  These stocks were ready for a correction and today they got it.

 

Sorrento leads the way - up 30% on COVID TEST news

Sorrento rocks up by 30% on the potential for FDA approval of a COVID test. NantKwest also strong, up 7%. The top COVID VACCINE STOCK, Novavax has another great day, up almost 5%. 

Otherwise, it was a relatively flat day, with the stocks just barely positive, up around 0.5%. Conversely, 15 stocks were down and 12 were up. GeoVax lead on the downside, giving up 10% after announcing earnings.

 

Another down day to finish the week - Sorrento the winner, Dynavax the loser.

Another down day for COVID VACCINE STOCKS - falling on average 2.3%. Paradoxically, a majority (14) of the stocks were up, with 12 going down with VBI flat.Sorrento Therapeutics was the top performer -- up 5.5%. Dynavax was the big loser on an earnings miss -- dropping just over 13%.

 

COVID VACCINE STOCKS GET HAMMERED - 24 of 27 fall.

Taking us back to the dark days of July 23 -24, the red ink flowed today. There were only four COVID VACCINE STOCKS that eked out tiny gains. The rest of the stocks fell. Only PDS Bio suffered a double digit loss--down over 11%, but lots of stocks got hit hard.The average COVID VACCINE STOCK fell by 3.26%, which is less of a loss than we saw on the two down days last week.  The excitement and mild controversy over Novavax Phase I results may have pushed these stocks into hangover mode. Perhaps we're into the dog days of summer. Let's see what happens tomorrow on the last trading day this week.

VAXART top COVID VACCINE STOCK after NOVAVAX presents Phase I results

A wild day with COVID VACCINE STOCKS, after Novavax presents some good news in a Phase I trial. Stat news messed up its news story initially, resulting in a temporary deep dive in after hours. The stock closed at $169.90, up 8.1% after today's trading. Perhaps as a result of Novavax's progress, Moderna dropped 4.2%. 

The winning stock today was Vaxart, up 10.4%. Other strong performers were Emergent (which has arrangements with Novavax for production and distribution of the vaccine) was up 8.2%. Inovio was up 7%, for its best day in some time.

Today's loser was GeoVax, down almost 11%. PDS Bio dropped 6.4%. 

Overall, it was a relatively flat day with 14 stocks down and 13 up. The average COVID VACCINE STOCK was up 0.7%.

Sorrento Therapeutics adds one third in value. Slight gain overall -- up 1.2% on average

Sorrento Therapeutics had a great day - up over 31%. 

The rest of the COVID VACCINE STOCKS were relatively flat with an average gain of 1.2%. Sixteen were up with eleven down.

PDS Bio was up over 8.5% and GeoVax was up 5.5%. Emergent had another strong day - up almost 4%. Altimmune had another good day, gaining over 3%. 

On the down side, Atara Bio and NantKwest fell over 8%.

Novavax release of Phase I info causes firestorm in after hours trading: 

https://www.statnews.com/2020/08/04/novavaxs-covid-19-vaccine-shows-promising-immune-response-early-data-show/

COVID VACCINE STOCKS take off! PDS #1

 

Happy days are here again! COVID VACCINE STOCKS take off with a vengeance.

It has been exactly two weeks since these stocks registering such a blow out day. These companies were up just under 5% on average.

Fully 22 of the 27 stocks were up - some way up.

PDS Biotechnology rocketed up the most, adding 17.5% to lead the way. GeoVax was next, up almost 14%. Both Biondvax and Dynavax were up over 10%. There were many companies up in the high single digits - including many of the big names like Moderna and NVAX.

https://www.wsj.com/articles/merck-2q-profit-rises-despite-lower-revenue-11596195476

This week's bottom COVID VACCINE STOCKS - DVAX out, TBIO in -- Emergent Bio moving up

Quite stable bottom 10 COVID VACCINE STOCKS with only DVAX climbing out and replaced by Translate Bio whose return fell from 138% to 100% since March 1. 

Generex Bio remains at the bottom with a loss of 55% since March 1. Its numbers are poor based on the March 1 selected date as it had just popped up to $1.41 and then went straight back down. 

Emergent Bio had the best week of the group with a strong close on Friday--going from a 62% return to 101%. The only other one of these stocks with a positive week was Adaptive Bio which went from a 29% to a 33% return.

Novavax gains on pack -- 798% return since March 1

Novavax still number one of all COVID VACCINE STOCKS with an amazing 794% return since March 1. 

The Top Ten are the same stocks again this week some minor re-shuffling. Sorrento has gone from 10th to 6th and Altimmune has gone from third to second.

Returns for the 27 COVID VACCINE STOCKS dropped to 198% in total, down from 215% last week. Novavax remains the leader of this group, gaining again this week from a return of 737% last week to 794% this week.

All but 2 of these stocks have a positive return since March 1.